LORAZEPAM INTENSOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lorazepam Intensol, and when can generic versions of Lorazepam Intensol launch?
Lorazepam Intensol is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in LORAZEPAM INTENSOL is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lorazepam Intensol
A generic version of LORAZEPAM INTENSOL was approved as lorazepam by SANDOZ on April 21st, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LORAZEPAM INTENSOL?
- What are the global sales for LORAZEPAM INTENSOL?
- What is Average Wholesale Price for LORAZEPAM INTENSOL?
Summary for LORAZEPAM INTENSOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 50 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,117 |
| Drug Prices: | Drug price information for LORAZEPAM INTENSOL |
| DailyMed Link: | LORAZEPAM INTENSOL at DailyMed |
Recent Clinical Trials for LORAZEPAM INTENSOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| California Institute of Technology | Phase 4 |
| Laureate Institute for Brain Research, Inc. | Phase 4 |
| National Institute of Mental Health (NIMH) | Phase 4 |
Pharmacology for LORAZEPAM INTENSOL
| Drug Class | Benzodiazepine |
US Patents and Regulatory Information for LORAZEPAM INTENSOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | LORAZEPAM INTENSOL | lorazepam | CONCENTRATE;ORAL | 072755-001 | Jun 28, 1991 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
